246 related articles for article (PubMed ID: 8156526)
1. The significance of nucleolar organizer region (AgNOR) score in predicting meningioma recurrence.
Kunishio K; Ohmoto T; Matsuhisa T; Maeshiro T; Furuta T; Matsumoto K
Cancer; 1994 Apr; 73(8):2200-5. PubMed ID: 8156526
[TBL] [Abstract][Full Text] [Related]
2. Recurrent and atypical meningiomas--a multiparametric study using Ki67 labelling index, AgNOR and DNA Feulgen staining.
Ferraraccio F; Accardo M; Giangaspero F; Cuccurullo L
Clin Neuropathol; 2003; 22(4):187-92. PubMed ID: 12908755
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of argyrophilic nucleolar organizer region staining in predicting the behavior of meningiomas.
Ahmadi SA; Samadi N
Ann Saudi Med; 2006; 26(1):38-42. PubMed ID: 16521873
[TBL] [Abstract][Full Text] [Related]
4. Nucleolar organizer regions in meningiomas. Correlation with histopathologic malignancy grading, DNA cytometry and clinical outcome.
Plate KH; Ruschoff J; Mennel HD
Anal Quant Cytol Histol; 1990 Dec; 12(6):429-38. PubMed ID: 2078265
[TBL] [Abstract][Full Text] [Related]
5. Morphometrical analysis of nucleolin immunohistochemistry in meningiomas.
Ohkoudo M; Sawa H; Shiina Y; Sato H; Kamata K; Iijima J; Yamamoto H; Fujii M; Saito I
Acta Neuropathol; 1996 Jul; 92(1):1-7. PubMed ID: 8811118
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of argyrophilic nucleolar organizer staining for predicting prognosis of patients with recurrent soft tissue sarcoma.
Kuratsu S; Ohsawa M; Naka N; Myoui A; Tomita Y; Uchida A; Ono K; Aozasa K
Oncology; 1994; 51(3):244-50. PubMed ID: 8196907
[TBL] [Abstract][Full Text] [Related]
7. Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas.
Matsuno A; Fujimaki T; Sasaki T; Nagashima T; Ide T; Asai A; Matsuura R; Utsunomiya H; Kirino T
Acta Neuropathol; 1996; 91(5):504-10. PubMed ID: 8740231
[TBL] [Abstract][Full Text] [Related]
8. Nucleolar organizer regions in meningiomas.
Radhakrishnan VV; Radhakrishnan NS; Rout D; Misna BK
Br J Neurosurg; 1993; 7(4):377-81. PubMed ID: 8216907
[TBL] [Abstract][Full Text] [Related]
9. Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor.
Tomobe M; Shimazui T; Uchida K; Hinotsu S; Akaza H
J Urol; 1999 Jul; 162(1):63-8. PubMed ID: 10379741
[TBL] [Abstract][Full Text] [Related]
10. Invasive meningioma: a tumour with high proliferating and "recurrence" potential.
Suwa T; Kawano N; Oka H; Ito H; Kameya T
Acta Neurochir (Wien); 1995; 136(3-4):127-31. PubMed ID: 8748841
[TBL] [Abstract][Full Text] [Related]
11. Proliferating cell nuclear antigen (PCNA) in atypical and malignant meningiomas.
Zimmer C; Gottschalk J; Cervos-Navarro J; Martin H; Beil M; Jautzke G
Pathol Res Pract; 1992 Dec; 188(8):951-8. PubMed ID: 1363764
[TBL] [Abstract][Full Text] [Related]
12. MIB1 staining index and scoring of histologic features in meningioma. Indicators for the prediction of biologic potential and postoperative management.
Ohta M; Iwaki T; Kitamoto T; Takeshita I; Tateishi J; Fukui M
Cancer; 1994 Dec; 74(12):3176-89. PubMed ID: 7982181
[TBL] [Abstract][Full Text] [Related]
13. Assessment of proliferative potential of meningiomas using PCNA LI and AgNOR counts.
Sudha K; Karak AK; Sharma MC; Mathur M; Sarkar C
Indian J Pathol Microbiol; 1998 Jul; 41(3):323-30. PubMed ID: 9805855
[TBL] [Abstract][Full Text] [Related]
14. [Ag-NORs, nucleus-nucleolus-associated antigens (Ki67, PCNA, P-105 and p-120): prognostic markers of meningioma recurrence].
Crafa P; Campanini N; Martella EM; Trabattoni G; Tedeschi F
Acta Biomed Ateneo Parmense; 1994; 65(5-6):297-308. PubMed ID: 8592922
[TBL] [Abstract][Full Text] [Related]
15. DNA topoisomerase II-alpha and cyclin A immunoexpression in meningiomas and its prognostic significance: an analysis of 263 cases.
Korshunov A; Shishkina L; Golanov A
Arch Pathol Lab Med; 2002 Sep; 126(9):1079-86. PubMed ID: 12204057
[TBL] [Abstract][Full Text] [Related]
16. Intracranial meningeal tumours in childhood: a clinicopathologic study including MIB-1 immunohistochemistry.
Demirtaş E; Erşahin Y; Yilmaz F; Mutluer S; Veral A
Pathol Res Pract; 2000; 196(3):151-8. PubMed ID: 10729919
[TBL] [Abstract][Full Text] [Related]
17. Proliferating cell nuclear antigen (PCNA) and nucleolar organizer regions (NORs) in benign, atypical and malignant meningiomas.
Lee MC; Kang MW; Yang BS; Park CS; Juhng SW; Jung S; Kim JH; Kim SH; Kang SS; Lee JH
Noshuyo Byori; 1995; 12(2):133-9. PubMed ID: 8867694
[TBL] [Abstract][Full Text] [Related]
18. [AgNOR in neurooncology].
Martin H; Gottschalk J; Hufnagl P; Beil M
Acta Histochem Suppl; 1992; 42():179-84. PubMed ID: 1584963
[TBL] [Abstract][Full Text] [Related]
19. MIB-1 immunostaining and DNA flow cytometry in meningiomas.
Yasue M; Akasaki Y; Numoto TR; Abe S; Abe T; Takeuchi Y; Tanaka J
Noshuyo Byori; 1996 Apr; 13(1):17-20. PubMed ID: 8916122
[TBL] [Abstract][Full Text] [Related]
20. Recurrence of meningiomas versus proliferating cell nuclear antigen (PCNA) positivity and AgNOR counting.
Demirtaş E; Yilmaz F; Ovül I; Oner K
Acta Neurochir (Wien); 1996; 138(12):1456-63. PubMed ID: 9030354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
